Our results also revealed that NFBTA down-regulated the genes containing AKT1, AKT2, DVL1, EGFR, KRAS, and PIK3R1. Increased levels of serine/threonine kinases (AKTs) were detected in about 80% of all GBM cases. The gene discussed is AKT2; the disease is glioblastoma.